Trial · NCT02872116
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Pre-Treatment | STARTED | Arm 1: Nivolumab + Chemotherapy (XELOX or FOLFOX) | 789 | |
| Pre-Treatment | STARTED | Arm 2: Chemotherapy (XELOX or FOLFOX) | 833 | |
| Pre-Treatment | STARTED | Arm 3: Nivolumab + Ipilimumab | 409 | |
| Pre-Treatment | COMPLETED | Arm 1: Nivolumab + Chemotherapy (XELOX or FOLFOX) | 782 | |
| Pre-Treatment | COMPLETED | Arm 2: Chemotherapy (XELOX or FOLFOX) | 806 | |
| Pre-Treatment | COMPLETED | Arm 3: Nivolumab + Ipilimumab | 403 | |
| Pre-Treatment | NOT COMPLETED | Arm 1: Nivolumab + Chemotherapy (XELOX or FOLFOX) | 7 | |
| Pre-Treatment | NOT COMPLETED | Arm 2: Chemotherapy (XELOX or FOLFOX) | 27 | |
| Pre-Treatment | NOT COMPLETED | Arm 3: Nivolumab + Ipilimumab | 6 | |
| Treatment | STARTED | Arm 1: Nivolumab + Chemotherapy (XELOX or FOLFOX) | 782 | |
| Treatment | STARTED | Arm 2: Chemotherapy (XELOX or FOLFOX) | 806 | |
| Treatment | STARTED | Arm 3: Nivolumab + Ipilimumab | 403 | |
| Treatment | COMPLETED | Arm 1: Nivolumab + Chemotherapy (XELOX or FOLFOX) | 623 | |
| Treatment | COMPLETED | Arm 2: Chemotherapy (XELOX or FOLFOX) | 653 | |
| Treatment | COMPLETED | Arm 3: Nivolumab + Ipilimumab | 319 | |
| Treatment | NOT COMPLETED | Arm 1: Nivolumab + Chemotherapy (XELOX or FOLFOX) | 159 | |
| Treatment | NOT COMPLETED | Arm 2: Chemotherapy (XELOX or FOLFOX) | 153 | |
| Treatment | NOT COMPLETED | Arm 3: Nivolumab + Ipilimumab | 84 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02872116/flow